Sheila A Breidinger
Overview
Explore the profile of Sheila A Breidinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brainard D, Friedman E, Jin B, Breidinger S, Tillan M, Wenning L, et al.
J Clin Pharmacol
. 2010 May;
51(3):422-7.
PMID: 20457591
No abstract available.
2.
Iwamoto M, Hanley W, Petry A, Friedman E, Kost J, Breidinger S, et al.
Antimicrob Agents Chemother
. 2009 Feb;
53(5):1747-52.
PMID: 19223645
Raltegravir is a human immunodeficiency virus type 1 integrase strand transfer inhibitor with potent activity in vitro and in vivo. Raltegravir is primarily cleared by hepatic metabolism via glucuronidation (via...
3.
Iwamoto M, Wenning L, Nguyen B, Teppler H, Moreau A, Rhodes R, et al.
Clin Infect Dis
. 2009 Jan;
48(4):489-92.
PMID: 19143531
Raltegravir, a human immunodeficiency virus type 1 (HIV-1) integrase inhibitor, has pH-dependent solubility. Raltegravir plasma concentration increases with omeprazole coadministration in healthy subjects; this is likely secondary to an increase...
4.
Iwamoto M, Wenning L, Petry A, Laethem M, De Smet M, Kost J, et al.
Antimicrob Agents Chemother
. 2008 Oct;
52(12):4338-43.
PMID: 18838589
Raltegravir is a novel human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor with potent in vitro activity against HIV-1 (95% inhibitory concentration = 31 nM in 50% human...
5.
Wenning L, Friedman E, Kost J, Breidinger S, Stek J, Lasseter K, et al.
Antimicrob Agents Chemother
. 2008 Jul;
52(9):3253-8.
PMID: 18625763
Raltegravir is a novel human immunodeficiency virus type 1 (HIV-1) integrase inhibitor with potent in vitro activity (95% inhibitory concentration of 31 nM in 50% human serum). This article reports...